Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Hapvida and Intermedica continue M&A binge through crisis

Brazilian listed HMOs (health management organisations) Hapvida Saude and Grupo Notre Dame Intermedica have resumed their M&A binge since July after a quiet second quarter, despite the pandemic continuing to rage throughout the country. 
September 29, 2020

Eugin process enters second-round – but will COVID impact valuation?

Sell-side advisors Perella Weinburg have shortlisted a dozen second-rounder bidders for Eugin, the global IVF arm of NMC Health, according to reports in Spain. A source tells HBI Eugin's recent figures have been significantly impacted by COVID - will it impact the valuation?
September 24, 2020

PWC on M&A drivers in Spanish healthcare sector

The Spanish private healthcare market has been one of Europe's most attractive for institutional investors of late with strong organic and inorganic growth opportunities. PWC Spain's deals leader for Healthcare & Pharma Jose Zarzalejos talks us through the drivers, movers and shakers in the six main sub-sectors: hospitals, imaging, oncology, care homes, IVF and dentistry.
September 24, 2020

CMA price tag looks embarrassingly high

Potentially embarrassing details of the acquisition of CMA-Medina, the largest independent lab group in Belgium by French player Biogroup have emerged. Articles in the Belgian business press suggest massive gross margins and speculation that CMA sold for €1bn.
September 24, 2020

Employer Paid for Healthcare – Hidden Global Opportunity

Some of the most impressive for-profit players are in the occupational healthcare space. But what are the wider opportunities beyond core countries such as the USA, Finland, Romania and Poland? Panelists include: Richard Sands, Group Strategy Advisor, Medicover, Karim Dhala, Director Corporate Services, Qualitas Health and Alex Goldsmith, CEO, Medigold Health.
September 11, 2020

Optegra sales process begins

Multiple sources tell HBI that UK, Czechia and Poland-based ophthalmology platform Optegra is for sale. We take a look at the detailed figures behind the prospective sale, speculate as to price and buyers, and speak to an operator source about his view of the business.
September 10, 2020

EXCLUSIVE: Dutch mental health operator for sale

HBI hears that PE-backed Dutch mental health provider Mentaal Beter is for sale, with both private equity and international sector operators interested. A local consultant tells us why this is an attractive buy.
September 10, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us